Voltage-gated sodium channel α-subunit (NaV α-subunit)

The **voltage-gated sodium channel α-subunit** (NaV α-subunit) is the principal pore-forming component of sodium channels that mediates the rapid influx of sodium ions in response to membrane depolarization, initiating and propagating action potentials in excitable cells such as neurons, skeletal muscle, and cardiac muscle[1][4][7]. The α-subunit is a large (approximately 260 kDa) transmembrane protein organized into four homologous domains (I–IV), each containing six membrane-spanning segments (S1–S6); the S4 segment of each domain acts as the voltage sensor, while segments S5 and S6, and the intervening P-loop, form the ion-selective pore[1][4][7]. The intracellular loop between domains III and IV is critical for fast inactivation[1]. The α-subunit can function independently to form a conducting channel, though association with β-subunits modifies kinetics, voltage dependence, and localization[5][7]. There are multiple isoforms (NaV1.1 – NaV1.9), each with tissue-specific expression and biophysical properties[3][5]. These channels are essential drug targets for the treatment of pain, epilepsy, cardiac arrhythmias, and other disorders involving hyperexcitability, but clinical application is challenged by subtype similarity, leading to potential off-target adverse effects[2][3][8]. Multiple classes of drugs, including **local anesthetics**, **anticonvulsants**, and **antiarrhythmics**, act by inhibiting NaV α-subunits[6][3]. The channel is also targeted by various natural toxins, which have contributed to understanding its structure–function relationships[7][2]. Mutations in α-subunit genes cause a spectrum of hereditary channelopathies, serving both as disease mechanisms and diagnostic biomarkers[3][9]. Safety concerns center on cardiac and CNS toxicity, emphasizing the need for improved subtype-selective modulators[2][8].

Other names

Sodium channel protein alpha subunitNaV alpha subunitSodium channel alpha subunitNaV1.1 α-subunitSCN1A α-subunit

Blockade of sodium influx by binding to pore (local anesthetics, antiarrhythmics, anticonvulsants); State-dependent inhibition (open/inactivated state block); Stabilization of inactivated channel state; Modulation by neurotoxins (scorpion toxins, tetrodotoxin)